‘A chilling effect’: China biotech will slow as it nears R&D frontier, Pfizer’s Baum predicts

Andrew Baum speaks with Endpoints News' Drew Armstrong at MIT, Aug. 6, 2026 (Samantha Barracca for Endpoints News)

August 7, 2026 11:00 AM EDT

‘A chill­ing ef­fect’: Chi­na biotech will slow as it nears R&D fron­tier, Pfiz­er’s Baum pre­dicts

Chi­na’s rapid ad­vance in biotech will slow as com­pa­nies there be­gin to ex­per­i­ment on the cut­ting edge of R&D, ac­cord­ing to Pfiz­er’s An­drew Baum, who …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.